Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Although the deleterious vasoconstrictive effects of cell-free, hemoglobin-based blood substitutes have been appreciated, the systemic effects of chronic hemolysis on nitric oxide bioavailability have not been considered or quantified. Central to this investigation is the understanding that nitric oxide reacts at least 1,000 times more rapidly with free hemoglobin solutions than with erythrocytes. We hypothesized that decompartmentalization of hemoglobin into plasma would divert nitric oxide from homeostatic vascular function. We demonstrate here that plasma from patients with sickle-cell disease contains cell-free ferrous hemoglobin, which stoichiometrically consumes micromolar quantities of nitric oxide and abrogates forearm blood flow responses to nitric oxide donor infusions. Therapies that inactivate plasma hemoglobin by oxidation or nitric oxide ligation restore nitric oxide bioavailability. Decompartmentalization of hemoglobin and subsequent dioxygenation of nitric oxide may explain the vascular complications shared by acute and chronic hemolytic disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Priapism, nephropathy, and sickle vasculopathy are associated with hemolysis.”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [59]
In the citing paper
“In these complications HbF has a less obvious beneficial effect, perhaps because only a small number of lysed sickle erythrocytes are needed to trigger these subphenotypes.59”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [59]
In the citing paper
“As HbF falls and fewer F-cells are protected from HbS polymer damage, the propensity for vascular occlusion and intravascular hemolysis increases with the release of heme products into the circulation that scavenge nitric oxide causing endothelial damage and vasculopathy.[57][58][59]”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [59]
In the citing paper
“A further consequence of sickling of cells is increased RBC hemolysis. Hemolysis affects not only the number of circulating RBCs but also release of Hb (and other cytoplasmic proteins) within the blood stream, thus profoundly affecting the viscosity and colloid properties of plasma and increasing systemic NO scavenging (71, 152).”
From Red Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia (2017) · cites this paper as [152]
In the citing paper
“For example, in hemolytic anemia, release of free Hb may lead to systemic NO scavenging, affecting vascular tone (71, 152).”
From Red Blood Cell Function and Dysfunction: Redox Regulation, Nitric Oxide Metabolism, Anemia (2017) · cites this paper as [152]
Citations
Cites
De Caterina, R., Libby, P., Peng, H. B., Thannickal, V. J., Rajavashisth, T. B., Gimbrone, M. A., Shin, W. S., & Liao, J. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118074 · Cited by 1,782
Identification of the haemoglobin scavenger receptor
Kristiansen, M., Graversen, J. H., Jacobsen, C., Sonne, O., Hoffman, H.-J., Law, S. K. A., & Moestrup, S. K. (2001) · Nature · doi:10.1038/35051594 · Cited by 1,712
Mechanism of NO-induced oxidation of myoglobin and hemoglobin
Eich, R. F., Li, T., Lemon, D. D., Doherty, D. H., Curry, S. R., Aitken, J. F., Mathews, A. J., Johnson, K. A., Smith, R. D., Phillips, et al. (1996) · Biochemistry · doi:10.1021/bi960442g · Cited by 613
Diffusion-limited reaction of free nitric oxide with erythrocytes
Liu, X., Miller, M. J. S., Joshi, M. S., Sadowska-Krowicka, H., Clark, D. A., & Lancaster, J. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18709 · Cited by 512
A Tutorial on the Diffusibility and Reactivity of Free Nitric Oxide
Lancaster, J. R. (1997) · Nitric Oxide · doi:10.1006/niox.1996.0112 · Cited by 495
Nitric oxide in the human respiratory cycle
McMahon, T. J., Moon, R. E., Luschinger, B. P., Carraway, M. S., Stone, A. E., Stolp, B. W., Gow, A. J., Pawloski, J. R., Watke, P., Singel, D. J., et al. (2002) · Nature Medicine · doi:10.1038/nm718 · Cited by 469
Gladwin, M. T., Shelhamer, J. H., Schechter, A. N., Pease-Fye, M. E., Waclawiw, M. A., Panza, J. A., Ognibene, F. P., & Cannon, R. O. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.21.11482 · Cited by 441
Self-citationRate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin
Doherty, D. H., Doyle, M. P., Curry, S. R., Vali, R. J., Fattor, T. J., Olson, J. S., & Lemon, D. D. (1998) · Nature Biotechnology · doi:10.1038/nbt0798-672 · Cited by 432
Autoxidation kinetics of aqueous nitric oxide
Ford, P. C., Wink, D. A., & Stanbury, D. M. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81748-o · Cited by 419
Research works printed but not linked: 3
- Vaughn, M.W., Kuo, L. & Liao, J.C. Effective diffusion distance of nitric oxide in the microcirculation. Am. J. Physiol. 274, H1705–H1714 (1998).
- Vogel, W.M., Dennis, R.C., Cassidy, G., Apstein, C.S. & Valeri, C.R. Coronary constrictor effect of stroma-free hemoglobin solutions. Am. J. Physiol. 251, H413–H420 (1986).
- Pohl, U. & Lamontagne, D. Impaired tissue perfusion after inhibition of endothelium-derived nitric oxide. Basic Res. Cardiol. 86, 97–105 (1991).
Cited by
Items 101–200 of 1,000
Boretti, F. S., Buehler, P. W., D’Agnillo, F., Kluge, K., Glaus, T., Butt, O. I., Jia, Y., Goede, J., Pereira, C. P., Maggiorini, M., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39115 · Cited by 196
N-Terminal Pro-Brain Natriuretic Peptide Levels and Risk of Death in Sickle Cell Disease
Machado, R. F., Anthi, A., Steinberg, M. H., Bonds, D., Sachdev, V., Kato, G. J., Taveira-DaSilva, A. M., Ballas, S. K., Blackwelder, W., Xu, X., et al. (2006) · JAMA · doi:10.1001/jama.296.3.310 · Cited by 197
Self-citationHemoglobin and Heme Scavenger Receptors
Nielsen, M. J., Møller, H. J., & Moestrup, S. K. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2792 · Cited by 172
“Such Hb-mediated scavenging of NO reduces the bioavailability of NO and thus impedes NO homeostasis (95, 98).”
Hemolysis and cell-free hemoglobin drive an intrinsic mechanism for human disease
Gladwin, M. T., Kanias, T., & Kim-Shapiro, D. B. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62972 · Cited by 196
Self-citationMorris, C. R., Suh, J. H., Hagar, W., Larkin, S., Bland, D. A., Steinberg, M. H., Vichinsky, E. P., Shigenaga, M., Ames, B., Kuypers, F. A., et al. (2008) · Blood · doi:10.1182/blood-2007-04-081703 · Cited by 191
Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles
Merle, N. S., Grunenwald, A., Rajaratnam, H., Gnemmi, V., Frimat, M., Figueres, M.-L., Knockaert, S., Bouzekri, S., Charue, D., Noe, R., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.96910 · Cited by 189
Reactive oxygen and nitrogen species in pulmonary hypertension
Tabima, D. M., Frizzell, S., & Gladwin, M. T. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.02.041 · Cited by 184
“This reaction oxidizes NO to nitrate and inhibits its ability to vasodilate [82, 83].”
BackgroundSelf-citationCoagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension
Ataga, K. I., Moore, C. G., Hillery, C. A., Jones, S., Whinna, H. C., Strayhorn, D., Sohier, C., Hinderliter, A., Parise, L. V., & Orringer, E. P. (2008) · Haematologica · doi:10.3324/haematol.11763 · Cited by 187
“decreased nitric oxide availability, a finding in agreement with previous studies.(9,37) Nitric oxide decreases cytokine-”
BackgroundResultNitric Oxide Scavenging by Red Blood Cells as a Function of Hematocrit and Oxygenation
Azarov, I., Huang, K. T., Basu, S., Gladwin, M. T., Hogg, N., & Kim-Shapiro, D. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509045200 · Cited by 189
Self-citationHemodialysis‐induced cardiovascular disease
Ahmadmehrabi, S., & Tang, W. H. W. (2018) · Seminars in Dialysis · doi:10.1111/sdi.12694 · Cited by 175
“Nitric oxide bioavailability is tightly linked with hemoglobin levels, with cell-free hemoglobin scavenging NO 1000 times more rapidly than red blood cells.(80,81) When hemoglobin escapes red blood cells, a process deemed decompartmentalization, the bioavailability of NO decreases dramati-”
BackgroundMenon, A. V., Liu, J., Tsai, H. P., Zeng, L., Yang, S., Asnani, A., & Kim, J. (2022) · Blood · doi:10.1182/blood.2020008455 · Cited by 187
Mechanisms of hemolysis‐associated platelet activation
Helms, C. C., Marvel, M., Zhao, W., Stahle, M., Vest, R., Kato, G. J., Lee, J. S., Christ, G., Gladwin, M. T., Hantgan, R. R., et al. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12422 · Cited by 183
Self-citationPulmonary Complications of Sickle Cell Disease
Miller, A. C., & Gladwin, M. T. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201111-2082ci · Cited by 180
Self-citationTaylor, J. G., Nolan, V. G., Mendelsohn, L., Kato, G. J., Gladwin, M. T., & Steinberg, M. H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002095 · Cited by 184
“Protective associations with priapism and leg ulcers are consistent with effects on bioavailable NO [1,2].”
Self-citationPathophysiology and treatment of pulmonary hypertension in sickle cell disease
Gordeuk, V. R., Castro, O. L., & Machado, R. F. (2016) · Blood · doi:10.1182/blood-2015-08-618561 · Cited by 177
Sildenafil in the treatment of pulmonary hypertension
Barnett, C. F., & Machado, R. F. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.4.411 · Cited by 180
“A hemolysis-mediated decrease in NO bioavailability (Reiter et al 2002) increased production of endothelin-1 and free radicals, platelet activation, and endothelial dysfunction along with chronic hypoxia, and a prothrombotic state occurs in hemolytic disorders resulting in PAH (Machado and Gladwin…”
BackgroundSickle Cell Disease: New Opportunities and Challenges in Africa
Makani, J., Ofori-Acquah, S. F., Nnodu, O., Wonkam, A., & Ohene-Frempong, K. (2013) · The Scientific World Journal · doi:10.1155/2013/193252 · Cited by 175
“The latter has recently been shown to be associated with reduced bioavailability of nitric oxide [19], which has resulted in the development of potential therapies such as L-arginine, citrulline, and inhaled nitric oxide which is aimed at increasing NO levels through different pathways [153–157].”
BackgroundNitric Oxide Decreases Acute Kidney Injury and Stage 3 Chronic Kidney Disease after Cardiac Surgery
Lei, C., Berra, L., Rezoagli, E., Yu, B., Dong, H., Yu, S., Hou, L., Chen, M., Chen, W., Wang, H., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201710-2150oc · Cited by 176
Weiner, D. L., Hibberd, P. L., Betit, P., Cooper, A. B., Botelho, C. A., & Brugnara, C. (2003) · JAMA · doi:10.1001/jama.289.9.1136 · Cited by 178
“Time from onset of pain to morphine receipt, median (range), h 17 (3-114) 14 (1-83)”
Inborn defects in the antioxidant systems of human red blood cells
van Zwieten, R., Verhoeven, A. J., & Roos, D. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.11.022 · Cited by 179
Deuel, J. W., Schaer, C. A., Boretti, F. S., Opitz, L., Garcia-Rubio, I., Baek, J. H., Spahn, D. R., Buehler, P. W., & Schaer, D. J. (2016) · Cell Death & Disease · doi:10.1038/cddis.2015.392 · Cited by 172
“interacts with ligands other than oxygen, namely nitric oxide (NO) and peroxides.(2,3) These reactions are related to NO depletion and vascular dysfunction and may trigger oxidative”
BackgroundHemolysis is associated with acute kidney injury during major aortic surgery
Vermeulen Windsant, I. C., Snoeijs, M. G., Hanssen, S. J., Altintas, S., Heijmans, J. H., Koeppel, T. A., Schurink, G. W. H., Buurman, W. A., & Jacobs, M. J. (2010) · Kidney International · doi:10.1038/ki.2010.24 · Cited by 176
Cardiac status in well‐treated patients with thalassemia major
Aessopos, A., Farmakis, D., Hatziliami, A., Fragodimitri, C., Karabatsos, F., Joussef, J., Mitilineou, E., Diamanti‐Kandaraki, E., Meletis, J., & Karagiorga, M. (2004) · European Journal of Haematology · doi:10.1111/j.1600-0609.2004.00304.x · Cited by 179
“restricting its negative effect on nitric oxide availability (29); finally, it decreases drastically”
BackgroundOxidative stress in β-thalassaemia and sickle cell disease
Voskou, S., Aslan, M., Fanis, P., Phylactides, M., & Kleanthous, M. (2015) · Redox Biology · doi:10.1016/j.redox.2015.07.018 · Cited by 173
Interplay between coagulation and vascular inflammation in sickle cell disease
Sparkenbaugh, E., & Pawlinski, R. (2013) · British Journal of Haematology · doi:10.1111/bjh.12336 · Cited by 171
“Plasma haem levels average 4 3 1 1 lmol/l in sickle cell patients, whereas it is undetectable in healthy controls (Reiter et al, 2002).”
BackgroundChallenges of alloimmunization in patients with haemoglobinopathies
Chou, S. T., Liem, R. I., & Thompson, A. A. (2012) · British Journal of Haematology · doi:10.1111/bjh.12061 · Cited by 173
“…outcomes in patients with SCD, even though the disruption of NO bioavailability caused, of haemolysis and release of cell free haemoglobin, has been consistently demonstrated in SCD and is probably responsible for the vasculopathy observed in this disorder (Reiter et al, 2002; Rother et al, 2005).”
BackgroundSolomon, S. B., Wang, D., Sun, J., Kanias, T., Feng, J., Helms, C. C., Solomon, M. A., Alimchandani, M., Quezado, M., Gladwin, M. T., et al. (2013) · Blood · doi:10.1182/blood-2012-10-462945 · Cited by 171
Self-citationErythrocytes and Vascular Function: Oxygen and Nitric Oxide
Helms, C. C., Gladwin, M. T., & Kim-Shapiro, D. B. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00125 · Cited by 161
“However, in multiple diseases RBC hemolysis occurs introducing cell-free Hb into the vasculature (Reiter et al., 2002; Sobolewski et al., 2005).”
BackgroundSelf-citationHemolysis, free hemoglobin toxicity, and scavenger protein therapeutics
Vallelian, F., Buehler, P. W., & Schaer, D. J. (2022) · Blood · doi:10.1182/blood.2022015596 · Cited by 167
Environmental determinants of severity in sickle cell disease
Tewari, S., Brousse, V., Piel, F. B., Menzel, S., & Rees, D. C. (2015) · Haematologica · doi:10.3324/haematol.2014.120030 · Cited by 158
Andersen, C. B. F., Stødkilde, K., Sæderup, K. L., Kuhlee, A., Raunser, S., Graversen, J. H., & Moestrup, S. K. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6793 · Cited by 168
Hebbel, R. P. (2011) · American Journal of Hematology · doi:10.1002/ajh.21952 · Cited by 169
“The HHP emphasizes the role of cell-free plasma Hb [16], although actual amount may have been substantially over-estimated because the method measured total plasma heme, rather than Hb per se.”
BackgroundMethodInfluentialMorris, C. R., Kuypers, F. A., Lavrisha, L., Ansari, M., Sweeters, N., Stewart, M., Gildengorin, G., Neumayr, L., & Vichinsky, E. P. (2013) · Haematologica · doi:10.3324/haematol.2013.086637 · Cited by 169
“resistance, NO inactivation, and impaired NO bioavailability.(10,12,13) Under conditions of increased inflammation or oxida-”
BackgroundJanz, D. R., Bastarache, J. A., Peterson, J. F., Sills, G., Wickersham, N., May, A. K., Roberts, L. J., & Ware, L. B. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182741a54 · Cited by 169
“various vascular beds (1, 2, 6, 8, 9), neutrophil activation (10),”
BackgroundWesterman, M., Pizzey, A., Hirschman, J., Cerino, M., Weil‐Weiner, Y., Ramotar, P., Eze, A., Lawrie, A., Purdy, G., Mackie, I., et al. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07155.x · Cited by 164
“Free Hb is considered to have a significant effect on bioavailability of NO (Reiter et al, 2002), so it could be important to determine the extent of the contribution of vesicle Hb to free plasma Hb.”
BackgroundPulmonary Hypertension and Cor Pulmonale during Severe Acute Chest Syndrome in Sickle Cell Disease
Mekontso Dessap, A., Leon, R., Habibi, A., Nzouakou, R., Roudot-Thoraval, F., Adnot, S., Godeau, B., Galacteros, F., Brun-Buisson, C., Brochard, L., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200710-1606oc · Cited by 170
Sickle cell disease and nitric oxide: A paradigm shift?
Kyle Mack, A., & Kato, G. J. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.01.010 · Cited by 163
“In contrast, cell-free plasma hemoglobin resulting from intravascular hemolysis consumes NO 1000-fold more rapidly (Liu et al., 1998), dramatically limiting NO bioavailability in patients with sickle cell disease (Reiter et al., 2002).”
BackgroundInfluentialGlomerular Hyperfiltration in Adult Sickle Cell Anemia: A Frequent Hemolysis Associated Feature
Haymann, J.-P., Stankovic, K., Levy, P., Avellino, V., Tharaux, P.-L., Letavernier, E., Grateau, G., Baud, L., Girot, R., & Lionnet, F. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08511109 · Cited by 170
“However, the presence of an abnormal vascular tone, such as a dysregulation of the myogenic response of afferent arterioles, leading to increased intrarenal blood flow, may also be at play (9,23) through a decreased nitric oxide (NO) availability (24) and endothelin activation, which have been reported in patients wit…”
BackgroundHemoglobin, nitric oxide and molecular mechanisms of hypoxic vasodilation
Allen, B. W., Stamler, J. S., & Piantadosi, C. A. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.08.002 · Cited by 165
Cardiovascular complications and risk of death in sickle-cell disease
Gladwin, M. T. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00647-4 · Cited by 164
Self-citationBiological activity of nitric oxide in the plasmatic compartment
Wang, X., Tanus-Santos, J. E., Reiter, C. D., Dejam, A., Shiva, S., Smith, R. D., Hogg, N., & Gladwin, M. T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402201101 · Cited by 164
Self-citationRed cell DAMPs and inflammation
Mendonça, R., Silveira, A. A. A., & Conran, N. (2016) · Inflammation Research · doi:10.1007/s00011-016-0955-9 · Cited by 158
Windsant, I. C. V., Wit, N. C. J. D., Sertorio, J. T. C., van Bijnen, A. A. J. H. M., Ganushchak, Y. M., Heijmans, J. H., Tanus-Santos, J. E., Jacobs, M. J. H. M., Maessen, J. G., & Buurman, W. A. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00340 · Cited by 167
Self-citationA network model to predict the risk of death in sickle cell disease
Sebastiani, P., Nolan, V. G., Baldwin, C. T., Abad-Grau, M. M., Wang, L., Adewoye, A. H., McMahon, L. C., Farrer, L. A., Taylor, J. G., Kato, G. J., et al. (2007) · Blood · doi:10.1182/blood-2007-04-084921 · Cited by 161
Self-citationBernaudin, F., Verlhac, S., Chevret, S., Torres, M., Coic, L., Arnaud, C., Kamdem, A., Hau, I., Grazia Neonato, M., & Delacourt, C. (2008) · Blood · doi:10.1182/blood-2008-03-143891 · Cited by 162
An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy
Reiter, C. D., & Gladwin, M. T. (2003) · Current Opinion in Hematology · doi:10.1097/00062752-200303000-00001 · Cited by 159
Self-citationHigdon, A. N., Benavides, G. A., Chacko, B. K., Ouyang, X., Johnson, M. S., Landar, A., Zhang, J., & Darley-Usmar, V. M. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00584.2011 · Cited by 161
“The toxic effects of free heme and heme proteins is well appreciated with evidence that it scavenges nitric oxide (NO) (23, 67, 72) decreasing blood flow (74) and further exacerbating the severity of ischemic episodes and potential damage to the endothelium.”
BackgroundAcquired Amino Acid Deficiencies: A Focus on Arginine and Glutamine
Morris, C. R., Hamilton‐Reeves, J., Martindale, R. G., Sarav, M., & Ochoa Gautier, J. B. (2017) · Nutrition in Clinical Practice · doi:10.1177/0884533617691250 · Cited by 160
“Under conditions of low arginine or cofactor tetrahydrobiopterin availability,103 NOS is uncoupled, producing reactive oxygen species in lieu of NO,104 which will further consume NO.”
BackgroundInfluentialBiomarkers in sickle cell disease
Rees, D. C., & Gibson, J. S. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08961.x · Cited by 177
“Haemolysis in SCD results in increased levels of free plasma haemoglobin, which has been shown to bind and inactivate nitric oxide (NO) (Reiter et al, 2002).”
BackgroundHill, A., Rother, R. P., Wang, X., Morris, Jr., Quinn‐Senger, K., Kelly, R., Richards, S. J., Bessler, M., Bell, L., Hillmen, P., et al. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08096.x · Cited by 158
“The role of haemolysis-produced cell-free plasma haemoglobin and NO depletion on systemic and PH has been explored in sickle cell disease (Reiter et al, 2002) and malaria (Aliyu et al, 2008) but has not been examined to date in other haemolytic diseases.”
BackgroundSelf-citationNewer Aspects of the Pathophysiology of Sickle Cell Disease Vaso-Occlusion
Conran, N., Franco‐Penteado, C. F., & Costa, F. F. (2009) · Hemoglobin · doi:10.1080/03630260802625709 · Cited by 182
Receptor targeting of hemoglobin mediated by the haptoglobins: roles beyond heme scavenging
Nielsen, M. J., & Moestrup, S. K. (2009) · Blood · doi:10.1182/blood-2009-01-198309 · Cited by 154
Bloodless medicine: clinical care without allogeneic blood transfusion
Goodnough, L. T., Shander, A., & Spence, R. K. (2003) · Transfusion · doi:10.1046/j.1537-2995.2003.00367.x · Cited by 152
Pulmonary hypertension in sickle cell disease
Ataga, K. I., Sood, N., Gent, G. D., Kelly, E. A., Henderson, A. G., Jones, S., Strayhorn, D., Lail, A. E., Lieff, S., & Orringer, E. P. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.03.034 · Cited by 152
Cardenes, N., Corey, C., Geary, L., Jain, S., Zharikov, S., Barge, S., Novelli, E. M., & Shiva, S. (2014) · Blood · doi:10.1182/blood-2013-09-529420 · Cited by 150
Protective effect of arginine on oxidative stress in transgenic sickle mouse models
Dasgupta, T., Hebbel, R. P., & Kaul, D. K. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.08.025 · Cited by 165
“In BERK mice as in human SCD, chronic depletion of arginine levels, reduced NO production, and NO consumption by the plasma heme as reported before [11,24,26,35] may all contribute to a proinflammatory milieu and in greater LPO levels.”
BackgroundInfluentialSachdev, V., Kato, G. J., Gibbs, J. S. R., Barst, R. J., Machado, R. F., Nouraie, M., Hassell, K. L., Little, J. A., Schraufnagel, D. E., Krishnamurti, L., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.032920 · Cited by 147
Self-citationHeme Inhibits Human Neutrophil Apoptosis: Involvement of Phosphoinositide 3-Kinase, MAPK, and NF-κB
Arruda, M. A., Rossi, A. G., de Freitas, M. S., Barja-Fidalgo, C., & Graça-Souza, A. V. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.2023 · Cited by 147
“(1), neutrophils incubated for 20 h in the absence (2) or the presence of 3”
BackgroundHemoglobin-mediated nitric oxide signaling
Helms, C., & Kim-Shapiro, D. B. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.04.028 · Cited by 146
“Oxidation of cell-free Hb (which remains mainly in the oxygenated form in plasma) to metHb has been recognized as a potential treatment strategy to counter NO scavenging by plasma cell-free Hb [8,94-97].”
BackgroundInfluentialSabaa, N., de Franceschi, L., Bonnin, P., Castier, Y., Malpeli, G., Debbabi, H., Galaup, A., Maier-Redelsperger, M., Vandermeersch, S., Scarpa, A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33308 · Cited by 140
Noubouossie, D. F., Key, N. S., & Ataga, K. I. (2015) · Blood Reviews · doi:10.1016/j.blre.2015.12.003 · Cited by 149
Recent developments in the understanding and management of paroxysmal nocturnal haemoglobinuria
Hill, A., Richards, S. J., & Hillmen, P. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06554.x · Cited by 140
“Once the capacity of this haemoglobin scavenging protein is exceeded, consumption of endogenous NO ensues (Pohl & Lamontagne, 1991; Reiter et al, 2002).”
BackgroundGordeuk, V. R., Sachdev, V., Taylor, J. G., Gladwin, M. T., Kato, G., & Castro, O. L. (2008) · American Journal of Hematology · doi:10.1002/ajh.21016 · Cited by 136
Self-citationOu, J., Ou, Z., Jones, D. W., Holzhauer, S., Hatoum, O. A., Ackerman, A. W., Weihrauch, D. W., Gutterman, D. D., Guice, K., Oldham, K. T., et al. (2003) · Circulation · doi:10.1161/01.cir.0000070589.61860.a9 · Cited by 138
Fetal hemoglobin in sickle cell anemia
Steinberg, M. H. (2020) · Blood · doi:10.1182/blood.2020007645 · Cited by 136
Sickle Cell Disease: Advances in Treatment
Gardner, R. V. (2018) · Ochsner Journal · doi:10.31486/toj.18.0076 · Cited by 144
Impaired vasodilation by red blood cells in sickle cell disease
Pawloski, J. R., Hess, D. T., & Stamler, J. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409876102 · Cited by 137
Hemodynamic Predictors of Mortality in Adults with Sickle Cell Disease
Mehari, A., Alam, S., Tian, X., Cuttica, M. J., Barnett, C. F., Miles, G., Xu, D., Seamon, C., Adams-Graves, P., Castro, O. L., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201207-1222oc · Cited by 135
“These markers have also been linked to accelerated hemolysis and alterations in nitric oxide bioavailability (48, 51).”
BackgroundBarst, R. J., Mubarak, K. K., Machado, R. F., Ataga, K. I., Benza, R. L., Castro, O. L., Naeije, R., Sood, N., Swerdlow, P. S., Hildesheim, M. E., et al. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08097.x · Cited by 136
“…vascular injury resulting from recurrent acute chest syndrome (ACS), and scavenging of nitric oxide by haemoglobin and arginase released during haemolysis also appear to contribute to the pulmonary vasculopathy (Reiter et al, 2002; Ataga et al, 2004; Morris et al, 2005; Gladwin & Vichinsky, 2008).”
Self-citationDetection of nitric oxide by electron paramagnetic resonance spectroscopy
Hogg, N. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.03.009 · Cited by 152
Self-citationVasculopathy and pulmonary hypertension in sickle cell disease
Potoka, K. P., & Gladwin, M. T. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00252.2014 · Cited by 133
Self-citationTsikas, D. (2008) · Analytical Biochemistry · doi:10.1016/j.ab.2008.04.018 · Cited by 142
Insight into the complex pathophysiology of sickle cell anaemia and possible treatment
Piccin, A., Murphy, C., Eakins, E., Rondinelli, M. B., Daves, M., Vecchiato, C., Wolf, D. G. F., Mahon, C. M., & Smith, O. P. (2019) · European Journal Of Haematology · doi:10.1111/ejh.13212 · Cited by 157
Nitric oxide production from hydroxyurea
King, S. B. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.02.073 · Cited by 133
Yeo, T. W., Lampah, D. A., Tjitra, E., Gitawati, R., Kenangalem, E., Piera, K., Granger, D. L., Lopansri, B. K., Weinberg, J. B., Price, R. N., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/644641 · Cited by 132
“with measurements of NO quenching, decreased NO-mediated vascular flow, and increased endothelial activation [11].”
InfluentialStorage lesion in banked blood due to hemolysis-dependent disruption of nitric oxide homeostasis
Gladwin, M. T., & Kim-Shapiro, D. B. (2009) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32833157f4 · Cited by 128
Self-citationHaemolysis and abnormal haemorheology in sickle cell anaemia
Connes, P., Lamarre, Y., Waltz, X., Ballas, S. K., Lemonne, N., Etienne-Julan, M., Hue, O., Hardy-Dessources, M.-D., & Romana, M. (2014) · British Journal of Haematology · doi:10.1111/bjh.12786 · Cited by 125
Does prolonged storage of red blood cells cause harm?
Flegel, W. A., Natanson, C., & Klein, H. G. (2014) · British Journal of Haematology · doi:10.1111/bjh.12747 · Cited by 136
Ischemia-reperfusion Injury in Sickle Cell Anemia
Hebbel, R. P. (2014) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2013.11.005 · Cited by 140
Wang, Q., & Zennadi, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124259 · Cited by 138
“Platelet aggregation can also be induced by RBCs through the release of hemoglobin, which lowers NO bioavailability [146,147].”
BackgroundEfficacy of red blood cell transfusion in the critically ill
Napolitano, L. M., & Corwin, H. L. (2004) · Critical Care Clinics · doi:10.1016/j.ccc.2003.12.002 · Cited by 127
Determination of extinction coefficients of human hemoglobin in various redox states
Meng, F., & Alayash, A. I. (2017) · Analytical Biochemistry · doi:10.1016/j.ab.2017.01.002 · Cited by 125
“These values are higher than those reported by others early, which are 2–33 mg/100 mL for SCD plasma [40, 41] and lower than 5 mg/100mL for normal plasma [42].”
BackgroundMerle, N. S., Paule, R., Léon, J., Daugan, M. V., Robe-Rybkine, T., Poillerat, V., Torset, C., Frémeaux‐Bacchi, V., Dimitrov, J. D., & Roumenina, L. T. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814797116 · Cited by 130
“RBC microvesicles, activating complement and carrying adhesive C3b deposits, as well as hemoglobin-mediated effects through NO scavenging, contribute to these hemolysis-mediated pathologic effects (64, 65).”
BackgroundGiustarini, D., Milzani, A., Dalle‐Donne, I., & Rossi, R. (2006) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.09.031 · Cited by 136
Derchi, G., Forni, G. L., Formisano, F., Cappellini, Galanello, R., D'Ascola, G., Bina, P., Magnano, C., & Lamagna, M. (2005) · PubMed · Cited by 125
Machado, R. F., & Gladwin, M. T. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05432.x · Cited by 128
“Chronic-inhaled NO could potentially be beneficial because of its ability to selectively dilate the pulmonary vasculature as well as oxidatively inactivate circulating plasma Hb (Reiter et al, 2002).”
BackgroundInfluentialSelf-citationZhou, Z., Han, H., Crúz, M. A., López, J. A., Dong, J.-F., & Guchhait, P. (2009) · Thrombosis and Haemostasis · doi:10.1160/th08-10-0677 · Cited by 123
Hemoglobins dioxygenate nitric oxide with high fidelity
Gardner, P. R., Gardner, A. M., Brashear, W. T., Suzuki, T., Hvitved, A. N., Setchell, K. D. R., & Olson, J. S. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2005.12.012 · Cited by 137
Cardiovascular surgery and organ damage: Time to reconsider the role of hemolysis
Windsant, I. C. V., Hanssen, S. J., Buurman, W. A., & Jacobs, M. J. H. M. (2011) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2011.02.012 · Cited by 123
“In patients with chronic high fHb levels as a result of sickle cell disease, forearm blood flow responses were reduced by 80% after infusion of the NO donor sodium nitroprusside relative to patients with below average fHb levels.(24) Third, hemolysis also results in release of arginase 1, an enzyme that converts L-arg…”
BackgroundInfluentialInhaled Nitric Oxide Enables Artificial Blood Transfusion Without Hypertension
Yu, B., Raher, M. J., Volpato, G. P., Bloch, K. D., Ichinose, F., & Zapol, W. M. (2008) · Circulation · doi:10.1161/circulationaha.107.729137 · Cited by 120
Machado, R. F., Kyle Mack, A., Martyr, S., Barnett, C., MacArthur, P., Sachdev, V., Ernst, I., Hunter, L. A., Coles, W. A., Nichols, J. P., et al. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06417.x · Cited by 122
“…al, 2005; Nolan et al, 2005; Rother et al, 2005; Kato et al, 2006), caused by the release of erythrocyte haemoglobin, which scavenges nitric oxide(Reiter et al, 2002), and erythrocyte arginase, which metabolises l-arginine, the substrate for nitric oxide synthesis (Morris et al, 2003; Schnog et…”
BackgroundSelf-citationJanz, D. R., Bastarache, J. A., Rice, T. W., Bernard, G. R., Warren, M. A., Wickersham, N. E., Sills, G., Oates, J. A., Roberts, L. J., & Ware, L. B. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000718 · Cited by 130
“In all of these patient populations, CFH has been associated with poor clinical outcomes thought to be mediated by the propensity of CFH to scavenge nitric oxide (1, 2, 5, 7, 8) and damage the vascular endothelium (11), as well as the detrimental ability of the iron moiety of CFH to oxidize lipid membranes and release…”
BackgroundSaraf, S. L., Zhang, X., Kanias, T., Lash, J. P., Molokie, R. E., Oza, B., Lai, C., Rowe, J. H., Gowhari, M., Hassan, J., et al. (2014) · British Journal of Haematology · doi:10.1111/bjh.12690 · Cited by 120
“In the ferrous state, iron will scavenge nitric oxide (NO) and participate in the Fenton reaction to generate hydroxyl radicals; both reduced NO and increased hydroxyl radicals can cause vasoconstriction, potentially impairing kidney perfusion (Reiter et al, 2002).”
BackgroundSelf-citationAlmeida, C. B., Scheiermann, C., Jang, J.-E., Prophete, C., Costa, F. F., Conran, N., & Frenette, P. S. (2012) · Blood · doi:10.1182/blood-2012-02-409524 · Cited by 116
Sickle cell anemia and vascular dysfunction: The nitric oxide connection
Akinsheye, I., & Klings, E. S. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22195 · Cited by 120
“There is evidence that inactivation of plasma hemoglobin by potassium cyanide treatment restores NO bioavailability (Reiter et al., 2002; Rother et al., 2005).”
BackgroundThe effect of fetal hemoglobin on the survival characteristics of sickle cells
Franco, R. S., Yasin, Z., Palascak, M. B., Ciraolo, P., Joiner, C. H., & Rucknagel, D. L. (2006) · Blood · doi:10.1182/blood-2005-09-008318 · Cited by 119
The Worst Things in Life are Free: The Role of Free Heme in Sickle Cell Disease
Gbotosho, O. T., Kapetanaki, M. G., & Kato, G. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.561917 · Cited by 136
Krishnan, S., Setty, Y. B. N., Betal, S. G., Vaidyula, V. R., Rao, K., Dampier, C., & Stuart, M. J. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.08013.x · Cited by 128
“Additionally, robust laboratory and animal data have further delineated the roles of hemolysis-related decreased nitric oxide bioavailability (Reiter et al, 2002), ischaemia-reperfusion injury (Kaul & Hebbel, 2000), and endothelial activation (Embury et al, 2004; Belcher et al, 2005) in…”
BackgroundSickle Cell Disease: Role of Oxidative Stress and Antioxidant Therapy
Vona, R., Sposi, N. M., Mattia, L., Gambardella, L., Straface, E., & Pietraforte, D. (2021) · Antioxidants · doi:10.3390/antiox10020296 · Cited by 135
“This reaction leads to the in vivo formation of •NO–hemoglobin deoxygenation end-products (methemoglobin, nitrate) and iron–nitrosylhemoglobin complexes, thus contributing to decrease •NO bioavailability [30].”
BackgroundMamikonian, L. S., Mamo, L. B., Smith, P. B., Koo, J., Lodge, A. J., & Turi, J. L. (2014) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000000047 · Cited by 116
Metadata
- Authors
- Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T.
- Affiliations
- National Institutes of Health (US)
- Medical College of Wisconsin (US)
- Corresponding author
- Gladwin, Mark T.
- Venue
- Nature Medicine
- Published
- 2002-11-11
- Volume
- 8
- Issue
- 12
- Pages
- 1383-1389
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W4241694836
- Semantic Scholar
- 80bbf9611dbe14c7276b2a4dbca6e42007866746
- Cited by
- 1,330
- References
- 45
- Citations by year
- 2026: 44 · 2025: 39 · 2024: 45 · 2023: 39 · 2022: 57 · 2021: 55 · 2020: 56 · 2019: 59 · 2018: 60 · 2017: 45 · 2016: 62 · 2015: 63 · 2014: 69 · 2013: 68 · 2012: 68
- FWCI
- 20.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (GM55792)
- National Center for Research Resources (P41RR001008, RR 01008)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Keywords
- free hemoglobin, nitric oxide bioavailability, sickle cell disease, chronic hemolysis, plasma hemoglobin, forearm blood flow, hemoglobin oxidation, vasoconstriction
- MeSH terms
- Adult, Anemia, Sickle Cell, Biological Availability, Heme, Hemocyanins, Hemoglobins, Hemolysis, Humans, Middle Aged, Nitric Oxide, Oxidation-Reduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.